LegoChem Biosciences, Inc. (141080.KQ)
KRW 96700.0
(-6.84%)
KRW 96700.0
(-6.84%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -71.38 Billion KRW | -51.07% |
| 2022 | -43.37 Billion KRW | -52.07% |
| 2021 | -17.52 Billion KRW | -16.64% |
| 2020 | -26.76 Billion KRW | -379.76% |
| 2019 | 16.98 Billion KRW | 164.42% |
| 2018 | -23.52 Billion KRW | -121.14% |
| 2017 | -9.5 Billion KRW | 10.21% |
| 2016 | -12.13 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -9.35 Billion KRW | -259.53% |
| 2024 Q1 | 4.06 Billion KRW | 123.32% |
| 2023 Q1 | -17.14 Billion KRW | 31.7% |
| 2023 Q2 | -15.79 Billion KRW | 7.86% |
| 2023 Q3 | -19.27 Billion KRW | -21.97% |
| 2023 Q4 | -24.71 Billion KRW | -28.25% |
| 2023 FY | - KRW | -51.07% |
| 2022 Q1 | -8.34 Billion KRW | -341.54% |
| 2022 FY | - KRW | -52.07% |
| 2022 Q3 | -9.39 Billion KRW | -16.28% |
| 2022 Q2 | -8.07 Billion KRW | 3.23% |
| 2022 Q4 | -25.1 Billion KRW | -167.32% |
| 2021 FY | - KRW | -16.64% |
| 2021 Q3 | -8.9 Billion KRW | 0.0% |
| 2021 Q4 | 3.45 Billion KRW | 138.81% |
| 2020 FY | - KRW | -379.76% |
| 2019 FY | - KRW | 164.42% |
| 2018 FY | - KRW | -121.14% |
| 2017 FY | - KRW | 10.21% |
| 2016 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 58.564% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | -1044.967% |
| BINEX Co., Ltd. | 10.87 Billion KRW | 756.59% |
| Bioneer Corporation | 10.04 Billion KRW | 810.776% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | -16204.418% |
| MEDIPOST Co., Ltd. | -19.39 Billion KRW | -268.121% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | -66.798% |
| Helixmith Co., Ltd | -53 Billion KRW | -34.678% |
| Chabiotech Co.,Ltd. | 70.08 Billion KRW | 201.85% |
| Medy-Tox Inc. | 32.69 Billion KRW | 318.314% |
| Peptron, Inc. | -12.65 Billion KRW | -464.283% |
| Amicogen, Inc. | 13.95 Billion KRW | 611.603% |
| Genexine, Inc. | -40.87 Billion KRW | -74.628% |
| HLB Therapeutics Co.,Ltd. | 8.22 Billion KRW | 967.416% |
| ALTEOGEN Inc. | 440.04 Million KRW | 16322.262% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 168.472% |
| SillaJen, Inc. | -17.35 Billion KRW | -311.381% |
| JETEMA, Co., Ltd. | 11 Billion KRW | 748.495% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | -541.081% |
| Genomictree Inc. | -6.33 Billion KRW | -1027.394% |
| MedPacto, Inc. | -32.6 Billion KRW | -118.914% |
| D&D Pharmatech | -9.05 Billion KRW | -688.093% |
| EASY BIO,Inc. | 24.32 Billion KRW | 393.484% |
| GI Innovation, Inc. | -51.33 Billion KRW | -39.069% |